Related Products
SSTR2 Protein Antibody Reagent
Product Name:
SSTR2 Protein Antibody Reagent
Item Number:
CTB076
Specifications
Somatostatin Receptor 2 (SSTR 2) Antibody Reagent (Immunohistochemistry)
Rabbit monoclonal antibody
121920D22
Cytoplasm, membrane
Meningioma
3/6/12ml
SSTR2 (Somatostatin receptor 2) is a G-protein-coupled cell membrane receptor. It is widely expressed in various normal organs and tissues, such as the pancreas, brain, kidneys, jejunum, colon, and liver. In tumors, it is mainly expressed in various neuroendocrine tumors and multiple solid tumors, such as pancreatic neuroendocrine tumors, pituitary adenomas, meningiomas, breast cancer, small cell lung cancer, and hormone-producing gastrointestinal tumors. Additionally, it is generally positively expressed in normal prostate tissue, whereas most prostate cancers are negative. Data indicate that SSTR2 can serve as a prognostic marker for octreotide drugs. Peptide receptor radionuclide therapy (PRRT) is one of the treatment methods for patients with metastatic neuroendocrine tumors; if the tumor tissue is negative for SSTR2 expression, radionuclide targeted therapy cannot be used. It is an independent predictor for improved overall survival and progression-free survival in neuroendocrine tumors; its expression in medullary thyroid carcinoma is associated with increased survival rates; and it is related to poor prognosis in hepatocellular carcinoma.
Contact Us
Category
微信公众号